Eli Casdin - Sep 29, 2022 Form 4 Insider Report for SomaLogic, Inc. (SLGC)

Role
Director
Signature
/s/ Eli Casdin
Stock symbol
SLGC
Transactions as of
Sep 29, 2022
Transactions value $
$0
Form type
4
Date filed
12/14/2022, 04:40 PM
Previous filing
Jun 17, 2022
Next filing
Oct 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLGC Class A Common Stock Award +215K +2.17% 10.1M Sep 29, 2022 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer and Palamedrix, Inc., the selling shareholders collectively received (i) 4,030,472 shares of Common Stock and (ii) 5,578,388 shares of Common Stock which may be issuable upon the achievement of certain milestones. The forgoing description of the Business Combination does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's S-3 filed on October 31, 2022, which is incorporated by reference.
F2 The securities are owned directly by Casdin Partners Master Fund, LP (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC.

Remarks:

Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.